Related Experiment Videos
[Fat infusion and carbohydrate metabolism]
Infusionstherapie Und Klinische Ernahrung
|June 1, 1983
Summary
Insulin resistance, common in type II diabetes, obesity, and critical illness, impairs the body's response to insulin. Understanding pre-receptor and post-receptor defects is key to managing this metabolic state.
Area of Science:
- Metabolic disorders
- Endocrinology
- Biochemistry
Context:
- Insulin resistance is prevalent in type II diabetes, obesity, and critically ill patients.
- It is characterized by reduced insulin sensitivity and/or responsiveness.
- Defects can occur pre-receptor, at the receptor, or post-receptor (intracellularly).
Purpose:
- To elucidate the mechanisms of insulin resistance in specific patient populations.
- To describe molecular defects contributing to impaired insulin action.
- To outline nutritional management strategies in insulin-resistant states.
Summary:
- Insulin resistance involves diminished insulin receptors and impaired intracellular signaling (e.g., phosphofructokinase, pyruvate dehydrogenase complex).
- This metabolic state favors fatty acid metabolism, potentially requiring intravenous fat support.
- Parenteral nutrition should include lipids, glucose, and amino acids unless contraindicated.
Impact:
- Provides a framework for understanding insulin resistance pathophysiology.
- Highlights the importance of nutritional support in managing metabolic derangements.
- Informs clinical practice regarding parenteral nutrition in insulin-resistant patients.